As well as being an Ambassador for the British Pharmacological Society, Dr Odeh is a leader in pharmacy fields and is driving success in others through ongoing development.

Dr Odeh has so far connected 17 Jordanian universities with the UK Queen’s University Belfast (QUB), resulting in more than 25 PhD student sponsorships and the launch of three Top Thought Leaders forums. He also founded the Pharmacy Management and Pharmaceutical Care Innovation Centre in Jordan. His expertise helped launch new Industrial and Pharmacy Management programmes for the first time in the Middle East.

As an Assistant Professor in Clinical Pharmacy, Dr Odeh has been celebrated for the quality of his work, with one article among the top 10% most cited PLoS ONE papers published in 2019 and another being featured as a top download by the British Journal of Clinical Pharmacology.

Dr Odeh has also received many local and international awards. He was selected for ‘’Best Researcher Award – International Research Award on Infectious Diseases 2021-22’’ and leads many committees in Jordan and the Middle East North Africa.

Dr Odeh has successfully created and led many Building Capacity and Personal Development Programs for various National and Arab world bodies. He has trained more than one thousand future leaders and enjoys helping others turn dreams into reality.

Dr Thamir Alshammari is an Associate of Pharmacy Practice and a Pharmacoepidemiology & Pharmacovigilance Consultant. He is also a distinguished expert for the Chinese National Drug Safety and Policy Centre at Xian, China.

Dr Alshammari is a senior researcher and Medication Safety Research Chair at the University of Hail. He has also served as Dean of the College of Pharmacy, University of Hail and as the Director of the National Pharmacovigilance and Drug Safety Centre, Saudi Food and Drug Authority (SFDA). He has taken on several initiatives during his work at SFDA including reviewing processes, benefit-risk analysis, DHCPLs and others. He is a member of several committees and he serves as a chair in some of them.

Dr Alshammari has over 65 publications in peer-reviewed journals and has been invited to many national and international conferences and meetings. He received both his bachelor degree in pharmaceutical sciences and his master degree in clinical pharmacy from King Saud University. Dr Alshammari received his PhD in pharmacoepidemiology and pharmacoeconomics from the University of Rhode Island, USA.

Dr Alshammari has completed several fellowships, including a post-doctoral fellowship at the Office of Surveillance and Epidemiology, US Food and Drug Administration (FDA). He is the only Saudi to have completed a post-doctoral fellowship at the FDA. Dr Alshammari also completed a pre-doctoral fellowship at Providence Veterans Affairs Medical Center in the USA.

His research interests include pharmacoepidemiology, pharmacovigilance and medication safety, and pharmacoeconomics.

Dr. Thikryat Neamatallah is an Associate Professor at the Department of Pharmacology and Toxicology, King Abdulaziz University KAU, Jeddah, Saudi Arabia. She obtained her Pharm. D degree from KAU in 2008, MSc degree in Forensic Toxicology from University of Glasgow in 2010 and Ph.D. degree in Pharmacology from the University of Strathclyde, in 2014

Her research interests are focused on the molecular mechanisms of intracellular signalling that regulate cellular functions such as proliferation and the immune responses. She is also interested in studying the signals between cancer cells and immune cells within the cancer microenvironment.

Dr Moustafa holds a Ph.D in Pharmaceutical Sciences “Medicinal Chemistry” (1991) awarded jointly by the University of Alexandria, Egypt and the University of Strathclyde. His research interests are in the synthesis of novel Dopaminergic compounds either agonists or antagonists. Since 2008 he has been Dean of the Oman Pharmacy Institute in Muscat.

Professor Naser Al-Tannak is a graduate of the Universities of Kuwait (B.Pharm Hons) and Strathclyde (MSc, PhD in Pharmaceutical Analysis) and is currently Assistant Professor in the Department of Pharmaceutical Chemistry at Kuwait University. He was a post-doctoral researcher and teaching fellow at Strathclyde. 

His research focuses on separation techniques, pharmaceutical dosage form analysis, natural product analysis and drug stability studies. Recent publications include: Antimycobacterial Activities of N-SubstitutedGlycinyl 1H1,2,3-Triazolyl Oxazolidinones and Analytical Method Development and Validation for a Representative Compound (2017) and UHPLC-UV Analysis of Morin and Structurally Related Flavonoids with Potential Anticancer Activity (2017)